4.7 Article

The insulinotropic effect of pulsatile compared with continuous intravenous delivery of GLP-1

Journal

DIABETOLOGIA
Volume 59, Issue 5, Pages 966-969

Publisher

SPRINGER
DOI: 10.1007/s00125-016-3878-7

Keywords

Glucagon; Glucagon-like peptide 1; Insulin; Pulsatile

Funding

  1. National Health and Medical Research Council (NHMRC) of Australia [1025648]
  2. NHMRC postgraduate scholarship
  3. NHMRC Early Career Fellowship

Ask authors/readers for more resources

In healthy individuals, both insulin and glucagon-like peptide 1 (GLP-1) are secreted in a pulsatile fashion. Insulin has greater glucose-lowering properties when administered in pulses compared with a constant i.v. infusion. The primary aim of this randomised double-dummy cross-over study was to compare the insulinotropic response to pulsatile and continuous i.v. infusions of equivalent doses of GLP-1. Twelve healthy participants aged 18-35 years were randomised to three different treatments on separate days: a continuous infusion day (GLP-1 at 0.6 pmol kg(-1) min(-1) [1 ml/min] and a 1 ml placebo bolus every 6 min); a pulsatile infusion day (placebo at 1 ml/min and a 3.6 pmol/kg GLP-1 bolus every 6 min); and a placebo day (placebo at 1 ml/min and a 1 ml placebo bolus every 6 min). Between 45 and 120 min, a hyperglycaemic clamp was used to maintain blood glucose at 9 mmol/l. Venous blood glucose and plasma insulin concentrations were measured every 5 min from 0 to 45 min and every 1 min from 45 to 120 min; plasma glucagon was measured every 15 min. The order of treatment was randomised by the Pharmacy Department and both study investigators and participants were blinded to the treatment arm. The dextrose requirement and glucagon data were analysed using repeated measures ANOVA and insulin data were analysed with a linear mixed effects maximum likelihood model. Continuous and pulsatile infusions of GLP-1 increased the dextrose requirement by similar to threefold (p < 0.001) and increased insulin secretion by similar to ninefold (p < 0.001). There was no difference in the effect of both treatments. Although hyperglycaemia reduced plasma glucagon concentrations, there was no difference between the treatment days. In healthy individuals, pulsatile and continuous administration of i.v. GLP-1 appears to have comparable insulinotropic effects. ACTRN12612001040853 This study was supported by the National Health and Medical Research Council (NHMRC) of Australia.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available